Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Stoll

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Case Reports in Rheumatology|October 13, 2018
Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab DiscontinuationElena Gonzalez-Rodriguez, Delphine Stoll, Olivier Lamy
Revue Medicale Suisse|July 29, 2011
[Testosterone and bone: indications and limitations]Delphine Stoll, Jardena J Puder, Olivier Lamy
Revue Medicale Suisse|July 21, 2017
[Phosphocalcic anomalies and bone fragility keys for the general practitioner]Bérengère Aubry-Rozier, Delphine Stoll, Elena Gonzalez-Rodriguez
Revue Medicale Suisse|September 28, 2017
Bérengère Aubry-Rozier, Delphine Stoll, Elena Rodriguez Gonzalez
Metabolism: Clinical and Experimental|December 19, 2003
Short-term administration of isotretinoin elevates plasma triglyceride concentrations without affecting insulin sensitivity in healthy humansDelphine Stoll, Christophe Binnert, Vincent Mooser, et al.
Current Osteoporosis Reports|February 2, 2020
Correction to: Stopping DenosumabOlivier Lamy, Delphine Stoll, Bérengère Aubry-Rozier, et al.
The Lancet. Oncology|May 3, 2019
Denosumab in early-stage breast cancerElena Gonzalez Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Current Osteoporosis Reports|January 20, 2019
Stopping DenosumabOlivier Lamy, Delphine Stoll, Bérengère Aubry-Rozier, et al.
Revue Medicale Suisse|April 18, 2019
[What can we do at the discovery of an osteroporotic vertebral fracture ?]Dorothée Brulhart, Delphine Stoll, Elena Gonzalez Rodriguez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Bisphosphonates as a First-Line Treatment for Glucocorticoid-Induced Osteoporosis: Comment on the Article by Saag et alElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Case Reports in Rheumatology|October 13, 2018
Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab DiscontinuationElena Gonzalez-Rodriguez, Delphine Stoll, Olivier Lamy
Revue Medicale Suisse|July 29, 2011
[Testosterone and bone: indications and limitations]Delphine Stoll, Jardena J Puder, Olivier Lamy
Revue Medicale Suisse|July 21, 2017
[Phosphocalcic anomalies and bone fragility keys for the general practitioner]Bérengère Aubry-Rozier, Delphine Stoll, Elena Gonzalez-Rodriguez
Revue Medicale Suisse|September 28, 2017
Bérengère Aubry-Rozier, Delphine Stoll, Elena Rodriguez Gonzalez
Metabolism: Clinical and Experimental|December 19, 2003
Short-term administration of isotretinoin elevates plasma triglyceride concentrations without affecting insulin sensitivity in healthy humansDelphine Stoll, Christophe Binnert, Vincent Mooser, et al.
Current Osteoporosis Reports|February 2, 2020
Correction to: Stopping DenosumabOlivier Lamy, Delphine Stoll, Bérengère Aubry-Rozier, et al.
The Lancet. Oncology|May 3, 2019
Denosumab in early-stage breast cancerElena Gonzalez Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Current Osteoporosis Reports|January 20, 2019
Stopping DenosumabOlivier Lamy, Delphine Stoll, Bérengère Aubry-Rozier, et al.
Revue Medicale Suisse|April 18, 2019
[What can we do at the discovery of an osteroporotic vertebral fracture ?]Dorothée Brulhart, Delphine Stoll, Elena Gonzalez Rodriguez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Bisphosphonates as a First-Line Treatment for Glucocorticoid-Induced Osteoporosis: Comment on the Article by Saag et alElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Pageof 3